Unknown

Dataset Information

0

Safety evaluation of a buffer used in the lyophilization of canine platelets: type I hypersensitivity reaction in dogs caused by bovine serum albumin.


ABSTRACT:

Introduction

The present study was designed to evaluate the safety of substances generally used in the preparation of lyophilized platelet products (LPPs) because the possibility of an immune response to bovine serum albumin (BSA) was considered high when using previously described technology.

Methods

An intradermal skin test, followed by a drug provocation test, was conducted to observe adverse events and identify the substances responsible for an immune response. Five male beagles (2 years old) weighing 12-14 kg were used. The dogs were clinically healthy and had no history of medication use. An intradermal skin test was conducted with each substance [i.e., 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid, sodium chloride, potassium chloride, sodium bicarbonate, theophylline, trehalose, and BSA] used in the conventional freeze-dry method.

Results

In the intradermal skin test, three dogs tested positive at the BSA injection site and showed clinical signs after the intradermal injection, including nausea and vomiting. For the drug provocation test, all dogs received two intravenous injections of an LPP buffer solution. The initial injection was devoid of BSA, whereas the subsequent injection contained BSA. The three dogs that had reacted to BSA in the intradermal skin test exhibited adverse events such as lethargy, vomiting, and nausea immediately after intravenous injection of the LPP buffer containing BSA. All dogs recovered uneventfully after symptomatic treatment in both tests.

Discussion

The high incidence and severity of type I hypersensitivity reactions observed in this study suggested that BSA is unsuitable as a component of canine LPP.

SUBMITTER: Choi HJ 

PROVIDER: S-EPMC10895064 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature

altmetric image

Publications

Safety evaluation of a buffer used in the lyophilization of canine platelets: type I hypersensitivity reaction in dogs caused by bovine serum albumin.

Choi Hee-Jae HJ   Kim Mu-Young MY   Han Hyun-Jung HJ  

Frontiers in veterinary science 20240212


<h4>Introduction</h4>The present study was designed to evaluate the safety of substances generally used in the preparation of lyophilized platelet products (LPPs) because the possibility of an immune response to bovine serum albumin (BSA) was considered high when using previously described technology.<h4>Methods</h4>An intradermal skin test, followed by a drug provocation test, was conducted to observe adverse events and identify the substances responsible for an immune response. Five male beagl  ...[more]

Similar Datasets

| S-EPMC6479529 | biostudies-literature
| S-EPMC8229831 | biostudies-literature
| S-EPMC5859114 | biostudies-literature
| S-EPMC7086924 | biostudies-literature
| S-EPMC3291441 | biostudies-literature
| S-EPMC2874359 | biostudies-literature
| S-EPMC7117211 | biostudies-literature
| S-EPMC7694820 | biostudies-literature
| S-EPMC8572576 | biostudies-literature
| S-EPMC7311061 | biostudies-literature